Priya Mande

Chief Executive Officer RNAvate

Priya Mande is Chief Executive Officer of RNAvate, focused on the development of novel circular RNA therapeutics.Priya is a founding member of PsiOxus Therapeutics and previously worked at Department for Business, Energy, and Industrial Strategy (BEIS) as a HMG Vaccine Taskforce and Vaccine Project Leader at Pfizer. Priya has a wealth of experience in transforming academic spin outs to award winning companies through raising capital, establishing & leading high performing teams, , deal making and creating shareholder and patient centric value.